TIA1 and fatty liver disease: Our bioinformatic analyses of publicly available databases or of mouse hepatic tissues did not allow for the observation of consistent alterations in TIA1 mRNA expression in human liver diseases (Supplementary Figure S4), neither in mouse models of hepatic steatosis nor inflammation (Supplementary Figure S5).